A look back at our 2017 ideas
In aggregate our analyst picks outperformed the FTSE All Share last year by 9% and the cumulative performance of our portfolio over 6 years would have given a total return of 300% (almost double the return on the FTSE All Share). In addition, many of our top-down themes played out very well such as our focus on secular growth in Tech, Life Sciences, Healthcare and Financials, an increase in M&A, our cautious stance on the Consumer and especially our bet on continue ....

02 Jan 2018
Best Ideas 2018
Aferian plc (AFRN:LON), 3.8 | Avingtrans plc (AVG:LON), 390 | CVS Group plc (CVSG:LON), 1,251 | Dunelm Group plc (DNLM:LON), 1,203 | EKF Diagnostics Holdings plc (EKF:LON), 25.6 | Fenner (FENR:LON), 0 | iomart Group plc (IOM:LON), 29.6 | M&C Saatchi plc (SAA:LON), 166 | MJ Gleeson PLC (GLE:LON), 524 | Realm Therapeutics (RLM:LON), 0 | Severfield Plc (SFR:LON), 31.2 | Premier Miton Global Renewables Trust Plc GBP (PMGR:LON), 98.5 | Realm Therapeutics (RLM:LON), 0 | Severfield Plc (SFR:LON), 31.2 | Statpro Group (SOG:LON), 0 | Verona Pharma plc Sponsored ADR (VRNA:NAS), 0

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Best Ideas 2018
Aferian plc (AFRN:LON), 3.8 | Avingtrans plc (AVG:LON), 390 | CVS Group plc (CVSG:LON), 1,251 | Dunelm Group plc (DNLM:LON), 1,203 | EKF Diagnostics Holdings plc (EKF:LON), 25.6 | Fenner (FENR:LON), 0 | iomart Group plc (IOM:LON), 29.6 | M&C Saatchi plc (SAA:LON), 166 | MJ Gleeson PLC (GLE:LON), 524 | Realm Therapeutics (RLM:LON), 0 | Severfield Plc (SFR:LON), 31.2 | Premier Miton Global Renewables Trust Plc GBP (PMGR:LON), 98.5 | Realm Therapeutics (RLM:LON), 0 | Severfield Plc (SFR:LON), 31.2 | Statpro Group (SOG:LON), 0 | Verona Pharma plc Sponsored ADR (VRNA:NAS), 0
- Published:
02 Jan 2018 -
Author:
Singer CM Team -
Pages:
4 -
A look back at our 2017 ideas
In aggregate our analyst picks outperformed the FTSE All Share last year by 9% and the cumulative performance of our portfolio over 6 years would have given a total return of 300% (almost double the return on the FTSE All Share). In addition, many of our top-down themes played out very well such as our focus on secular growth in Tech, Life Sciences, Healthcare and Financials, an increase in M&A, our cautious stance on the Consumer and especially our bet on continue ....